Table of Contents Author Guidelines Submit a Manuscript
Journal of Obesity
Volume 2011, Article ID 957268, 11 pages
http://dx.doi.org/10.1155/2011/957268
Clinical Study

Perspectives of CB1 Antagonist in Treatment of Obesity: Experience of RIO-Asia

1Department of Endocrinology, Chinese PLA, General Hospital, No. 28, Fuxing Road, Beijing 100853, China
2Division of Endocrinology and Metabolism, Department of Internal Medicine, Hangang Sacred Heart Hospital, 94-200, Yeongdeungpo-Dong, Yeongdeungpo-Gu Seoul 150-719, Republic of Korea
3Department of Medical Research & Education, Taipei Veterans General Hospital, No. 201, Sec. 2, Shih-Pai Road, Taipei 112, Taiwan
4Division of Endocrinology & Metabolism, Taipei Veterans General Hospital, No. 201, Sec. 2, Shih-Pai Road, Taipei 112, Taiwan
5Institute of Physiology, National Yang-Ming University, No. 155, Li-Nong Street, Taipei 112, Taiwan

Received 10 June 2010; Accepted 9 November 2010

Academic Editor: S. B. Heymsfield

Copyright © 2011 Changyu Pan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Changyu Pan, Hyung Joon Yoo, and Low-Tone Ho, “Perspectives of CB1 Antagonist in Treatment of Obesity: Experience of RIO-Asia,” Journal of Obesity, vol. 2011, Article ID 957268, 11 pages, 2011. https://doi.org/10.1155/2011/957268.